RDIF, Hetero agree to produce over 100 mn doses of Sputnik V vaccine in India

| | New Delhi
  • 0

RDIF, Hetero agree to produce over 100 mn doses of Sputnik V vaccine in India

Friday, 27 November 2020 | PTI | New Delhi

RDIF, Hetero agree to produce over 100 mn doses of Sputnik V vaccine in India

Russian Direct Investment Fund (RDIF) and pharma firm Hetero have agreed to produce over 100 million doses per year in India of the Sputnik V vaccine against COVID-19, Russia's sovereign wealth fund said in a statement.

The parties intend to start the production of Sputnik V in the beginning of 2021, it added.

Currently Phase III clinical trials are approved and are ongoing in Belarus, the UAE, Venezuela and other countries. Phase II-III trials are taking place in India, RDIF said.

State Editions

Covid-19: 18,442 vaccinated in State so far

26 January 2021 | PNS | Ranchi

Lokrang to start at Ravindra Bhavan from today

26 January 2021 | Staff Reporter | Bhopal

Cold wave, fog to prevail for next 24 hrs in State: MeT

26 January 2021 | Staff Reporter | Bhopal

CM urges MPs, MLAs, judges to adopt schools

26 January 2021 | PNS | Bhubaneswar

Economic blockade at Talcher launched

26 January 2021 | PNS | Bhubaneswar

Odisha tribal youth’s open-air gym draws praise

26 January 2021 | PNS | Bhubaneswar

Sunday Edition

Young go getter

24 January 2021 | Shalini Saksena | Sunday Pioneer

‘I don’t see what others are doing, I do my stuff’

24 January 2021 | Shalini Saksena | Sunday Pioneer

Modi, public will and intellectuals’ club

24 January 2021 | KK SRIVASTAVA | Agenda

Glued to gravity

24 January 2021 | MUSBA HASHMI | Sunday Pioneer

Desi twist to Western & Eastern flavours

24 January 2021 | Shalini Saksena | Sunday Pioneer

Talktime | ‘I don’t hesitate in giving retakes’

24 January 2021 | MUSBA HASHMI | Sunday Pioneer